Latest News & Updates

Breaking News

  • 1 minute ago

  • Vaibhavi M.

Roche Secures European Commission Approval For Obinutuzumab Combo Therapy, Marking A Major Advancement In Lupus Nephritis Treatment
Breaking News
Roche Secures CE Mark For Cobas BV/CV Assay, Advancing Accurate Diagnosis Of Vaginitis; Expands Roche’s Sexual Health Portfolio

Vaibhavi M.

Other trending news you may like to read

Roche Secures European Commission Approval For Obinutuzumab Combo Therapy, Marking A Major Advancement In Lupus Nephritis Treatment

Roche receives EU approval for Gazyva/Gazyvaro with MMF in active lupus nephritis, offering a new treatment option to slow kidney damage.

Vaibhavi M.

Pharma Now

Roche Secures CE Mark For Cobas BV/CV Assay, Advancing Accurate Diagnosis Of Vaginitis; Expands Roche’s Sexual Health Portfolio

Roche’s cobas BV/CV assay receives CE Mark, enabling accurate European testing for bacterial vaginosis and candida vaginitis with faster, precise results.

Vaibhavi M.

Pharma Now

FDA Approves Arcutis’ ZORYVE® Cream 0.05% For Treating Mild To Moderate Atopic Dermatitis In Children Aged 2–5

FDA approves ZORYVE cream 0.05% for atopic dermatitis in children aged 2 to 5, offering a non-steroidal, once-daily treatment option.

Simantini Singh Deo

Pharma Now

Moleculin Biotech Partners With Spain’s CIC biomaGUNE To Launch New Preclinical Studies Of Annamycin For Deadly Glioblastoma

Moleculin partners with CIC biomaGUNE to study Annamycin in preclinical glioblastoma models, expanding research into brain cancer treatment.

Simantini Singh Deo

Pharma Now